NASDAQ: BIOSBioplus Acquisition Corp Stock Ownership - Who owns Bioplus Acquisition?
Insider buying vs selling
Have Bioplus Acquisition Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when BIOS insiders and whales buy or sell their stock.
BIOS Shareholders
What type of owners hold Bioplus Acquisition Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Aristeia Capital LLC | 4.68% | 1,370,312 | $14.50M | Institution |
| Westchester Capital Management LLC | 4.46% | 1,306,594 | $13.82M | Institution |
| Cantor Fitzgerald L P | 4.32% | 1,265,102 | $13.38M | Institution |
| Polar Asset Management Partners Inc | 4.06% | 1,189,211 | $12.58M | Institution |
| Picton Mahoney Asset Management | 3.92% | 1,150,000 | $12.17M | Institution |
| Saba Capital Management LP | 3.55% | 1,041,845 | $11.02M | Institution |
| Linden Advisors LP | 3.41% | 1,000,000 | $10.58M | Institution |
| Calamos Advisors LLC | 3.41% | 1,000,000 | $10.58M | Institution |
| Meteora Capital LLC | 3.10% | 909,471 | $9.62M | Institution |
| D E Shaw Co Inc | 3.05% | 893,470 | $9.45M | Institution |
BIOS vs Shell Company Stocks
Bioplus Acquisition Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.